TATUM Bioscience
PrivateLast Round
Grant
Jun 18, 2026
Total Funding Raised
$5.8M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
TATUM Bioscience is a biotechnology company that develops next-generation immunotherapies using a proprietary synthetic biology platform to create multimodal nanofilaments for cancer treatment.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
TATUM Bioscience Comparables
Compare TATUM Bioscience with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Baccine Ltd. | 80% | |
| Sebastian BioPharma | 73% | |
| Theraphage | 73% |
TATUM Bioscience Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 18, 2026 | ||||
| Seed | Sep 1, 2025 | ||||
| Accelerator | Apr 10, 2025 | ||||
| Accelerator | May 21, 2024 | ||||
| Accelerator | Jun 30, 2022 |
TATUM Bioscience Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Consortium Québécois sur la découverte du médicament | Grant |
| Creative Destruction Lab | Accelerator |
| BoxOne Ventures | Seed |
| SCbioDrive | Accelerator |
| adMare BioInnovations | Accelerator |
| Sherbrooke Innopole | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 16, 2026
Monthly visitors increased 57% MoM.
- Sep 1, 2025
$6M raised from acet, BoxOne Ventures, and Sherbrooke Innopole.
TATUM Bioscience Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about TATUM Bioscience's valuation, stock price, and market status.
Is TATUM Bioscience a public or private company?
TATUM Bioscience is a private company.
What is the current stock price of TATUM Bioscience?
TATUM Bioscience is a private company with no public stock price. No recent secondary market data is available.
How much is TATUM Bioscience worth (valuation)?
Valuation information for TATUM Bioscience is not publicly available.
Can I buy TATUM Bioscience stock?
TATUM Bioscience shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was TATUM Bioscience's last funding round?
TATUM Bioscience's most recent funding round was Grant on June 18, 2026.
Who are the main investors in TATUM Bioscience?
Key investors in TATUM Bioscience include adMare BioInnovations.
Will TATUM Bioscience IPO soon?
No public IPO plans have been announced for TATUM Bioscience.
How can I track TATUM Bioscience secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor TATUM Bioscience's secondary market activity and sign up for updates.